Breaking News

Clondalkin Group Appoints CEO

February 4, 2013

Lennon to head global business development plans

David Lennon has been appointed global chief executive officer of the Pharmaceutical and Healthcare Division at Clondalkin Group. Mr. Lennon will head Clondalkin’s global business development plans and will work closely with the European and North American management teams. The division has invested almost $300 million during the past five years and plans to significantly increase the international packaging group’s geographical footprint and expand its current product offering.
 
Mr. Lennon joined the company in 2009 as chief executive officer of the European Pharma and Healthcare division. Mr. Lennon was responsible for the expansion of accredited pharmaceutical packaging facilities from three to eight sites through growth and strategic acquisition.
 
Clondalkin Group chief executive Norbert McDermott said, “We appointed David in 2009 because his pedigree as a senior executive as well as his packaging business expertise was clear.  In his four years with Clondalkin Group he has continued to prove himself to be an invaluable leader in consolidating our position as a leading producer of secondary pharmaceutical packaging where we now operate from 18 sites in North America and Europe. I am delighted to have David heading up the global development strategy of our Pharmaceutical and Healthcare Division and am confident of our continued success.”

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks